Enhanced therapeutic anti-tumor immunity induced by co-administration of 5-fluorouracil and adenovirus expressing CD40 ligand. [electronic resource]
Producer: 20140429Description: 273-82 p. digitalISSN:- 1432-0851
- Adenoviridae
- Animals
- Antibody Formation -- drug effects
- Antimetabolites, Antineoplastic -- administration & dosage
- Apoptosis -- drug effects
- CD40 Ligand -- genetics
- Cell Growth Processes -- drug effects
- Cell Line, Tumor
- Combined Modality Therapy
- Fas Ligand Protein -- metabolism
- Female
- Fluorouracil -- administration & dosage
- Humans
- Lymphocyte Activation -- drug effects
- Male
- Mice
- Mice, Inbred C57BL
- Mice, Nude
- Recombinant Proteins -- genetics
- T-Lymphocytes -- drug effects
- Urinary Bladder Neoplasms -- drug therapy
- fas Receptor -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.